Tomonaga Ichikawa

University of Miyazaki — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index2.9kcitations78works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mechanisms of cancer metastasis(18), T-cell and Retrovirus Studies(13), Vector-Borne Animal Diseases(9), Cancer-related gene regulation(8), Ubiquitin and proteasome pathways(7)

Publications75 total

Clathrin-associated SCYL2 contributes to the activation of PI3K/AKT signaling and tumorigenesis through PTEN phosphorylation in adult T-cell leukemia/lymphoma
Cancer Gene Therapy·2026Open Access
Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma
International Journal of Molecular Sciences·2024· 4 citedOpen Access
IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors
Frontiers in Oncology·2024· 1 citedOpen Access
Supplemental figure legends from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Data from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Supplemental figures from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
supplementary tables from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Supplemental figure legends from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Supplemental materials and methods from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Data from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
supplementary tables from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Supplemental materials and methods from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
Supplemental figures from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
2023Open Access
The CGRP Receptor Antagonist MK0974 Induces EVI1<sup>high</sup>AML Cell Apoptosis by Disrupting ERK Signaling
Anticancer Research·2022· 4 cited
Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma
Experimental Hematology·2022· 3 cited
Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer
Anticancer Research·2022· 10 cited
Inhibition of adult T‐cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis
Cancer Science·2022· 10 citedOpen Access
Role of Mel1/Prdm16 in bone differentiation and morphology
Experimental Cell Research·2021· 14 cited
Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells
PLoS ONE·2021· 25 citedOpen Access
Pathophysiological significance of N‐myc downstream‐regulated gene 2 in cancer development through protein phosphatase 2A phosphorylation regulation
Cancer Science·2020· 13 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Kazuhiro Morishita(24), Shingo Nakahata(21), Taixing Cui(12), Kazuya Shimoda(10), Teruo Watanabe(9), Jianglin Fan(9), Jinqing Li(8), Huijun Sun(8), Tomonari Koike(7), Jingyan Liang(7), Shuji Kitajima(6), Masatoshi Morimoto(5), Ryoji Yamaguchi(5), Hisataka Shikama(5), Hidekatsu Iha(5), Yusuke Saito(4), Tomohiro Tamura(4), Tomohiko Taki(4), Masafumi Taniwaki(4), Akira Suekane(4)